Evidence map›Paper›PMID 35027877›Full record

ArticleJournal of biomolecular techniques : JBT2021

Molecular Characterization of Increased Amplicon Lengths in SARS-CoV-2 Reverse Transcription Loop-Mediated Isothermal Amplification Assays.

Scott W Tighe, Andrew F Hayden, Marcy L Kuentzel, Korin M Eckstrom, Jonathan Foox, Daniel L Vellone, Kristiaan H Finstad, Pheobe K Laaguiby, Jessica J Hoffman, Sridar V Chittur

Abstract read
In one paragraph

Article in Journal of biomolecular techniques : JBT, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Scott W TigheUniversity of Vermont, Vermont Integrative Genomics, Burlington, Vermont 05405, USA.
Andrew F HaydenCenter for Functional Genomics, University at Albany-State University of New York, Rensselaer, NY 12144, USA.
Marcy L KuentzelCenter for Functional Genomics, University at Albany-State University of New York, Rensselaer, NY 12144, USA.
Korin M EckstromUniversity of Vermont, Vermont Integrative Genomics, Burlington, Vermont 05405, USA.
Jonathan FooxDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, 10021, USA.
Daniel L VelloneUniversity of Vermont, Vermont Integrative Genomics, Burlington, Vermont 05405, USA.
Kristiaan H FinstadUniversity of Vermont, Vermont Integrative Genomics, Burlington, Vermont 05405, USA.
Pheobe K LaaguibyUniversity of Vermont, Vermont Integrative Genomics, Burlington, Vermont 05405, USA.
Jessica J HoffmanUniversity of Vermont, Vermont Integrative Genomics, Burlington, Vermont 05405, USA.
Sridar V ChitturCenter for Functional Genomics, University at Albany-State University of New York, Rensselaer, NY 12144, USA.

Funding

Vermont Immunology/Infectious Diseases CenterP30GM118228 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2016 to 2021
$6.8M
NIGMS NIH HHS P30 GM118228
6 · The paper itself

Abstract

Loop-mediated isothermal amplification (LAMP) is a power tool for the amplification of specific RNA and DNA targets. Much like PCR, LAMP requires primers that surround a target amplification region and generates exponential product through a unique highly specific daisy-chain single-temperature amplification reaction. However, until recently, attempts to amplify targets of greater than 200 base pairs (bp) have been mostly unsuccessful and limited to short amplicon targets of less than 150 bp. Although short amplicons have the benefit of a rapid detection (<40 min), they do not allow for the prediction of RNA integrity based on RNA length and possible intactness. In this study, 8 primer sets were developed using 2 LAMP primer-specific software packages against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid gene with insert lengths ranging from 262 to 945 bp in order to amplify and infer the integrity of viral RNA. Because these amplification lengths are greater than the current methods that use an insert length of 130 or less, they require a longer incubation, modified primer and temperature strategies, and the addition of specific adjuncts to prevent nonspecific amplification. This proof of concept study resulted in successful reverse transcription LAMP reactions for amplicon targets of 262, 687, 693, and 945 bp using a clinical nasopharyngeal NP sample, purified SARS-CoV-2 RNA, and crude lysate containing inactivated virus.

Indexed as

COVID-19Reverse TranscriptionHumansMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesRNA, ViralSARS-CoV-2Sensitivity and SpecificityRNA, Viral

Identifiers

PMID35027877
PMCPMC8730522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.